Psychological issues in familial cancer

Pancreatic, hepatic and biliary malignancies

Administering systemic chemotherapy improves survival for patients with resectable CRCLM

Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in multiple myeloma patients

Trial argues strongly for the development of 1st-line biomarker selected strategies in pancreatic ductal adenocarcinoma

Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable hepatocellular carcinoma

Part 6: Which different PARP inhibitors are available

Part 7: Similarities and Differences

Part 8: How PARP inhibitors are being used now

Part 9: What PARP inhibitors mean for the future and what to look out for

Psilocybin-assisted psychotherapy for cancer-related anxiety and depression

Sudan: Conflict, cancer care, and ripple effects on the region